000 01684 a2200469 4500
005 20250516084902.0
264 0 _c20130109
008 201301s 0 0 eng d
022 _a1432-0584
024 7 _a10.1007/s00277-012-1459-5
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKiesewetter, Barbara
245 0 0 _aPrimary mucosa-associated lymphoid tissue (MALT) lymphoma of the liver: clinical, molecular, and microbiological aspects.
_h[electronic resource]
260 _bAnnals of hematology
_cNov 2012
300 _a1817-8 p.
_bdigital
500 _aPublication Type: Letter
650 0 4 _aAged
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aAustria
650 0 4 _aChromosomes, Human, Pair 14
_xgenetics
650 0 4 _aChromosomes, Human, Pair 18
_xgenetics
650 0 4 _aDNA, Bacterial
_xmetabolism
650 0 4 _aFemale
650 0 4 _aHelicobacter pylori
_xisolation & purification
650 0 4 _aHumans
650 0 4 _aLiver
_xmetabolism
650 0 4 _aLiver Neoplasms
_xdrug therapy
650 0 4 _aLymphoma, B-Cell, Marginal Zone
_xdrug therapy
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Recurrence, Local
_xdrug therapy
650 0 4 _aRemission Induction
650 0 4 _aRetrospective Studies
650 0 4 _aTranslocation, Genetic
700 1 _aMüllauer, Leonhard
700 1 _aStreubel, Berthold
700 1 _aAgis, Hermine
700 1 _aHirschl, Alexander
700 1 _aMakristathis, Athanasios
700 1 _aRaderer, Markus
773 0 _tAnnals of hematology
_gvol. 91
_gno. 11
_gp. 1817-8
856 4 0 _uhttps://doi.org/10.1007/s00277-012-1459-5
_zAvailable from publisher's website
999 _c21679053
_d21679053